The treatment outcomes in IgG4-related disease

Autor: Af, Karim, Rd, Bansie, Sm, Rombach, Dion Paridaens, Rm, Verdijk, Pm, Hagen, Jam, Laar

Publikováno v: Europe PubMed Central

IgG4-related disease (IgG4-RD) is an emerging systemic inflammatory disease involving nearly all organs eventually leading to fibrosis. Prompt and adequate treatment to prevent irreversible organ damage is therefore pivotal. To evaluate the treatment

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5f87d1ad4ce48f1e591adc6442e73d3e
https://pubmed.ncbi.nlm.nih.gov/30152392

The Impact of Spliceosome Inhibition in SF3B1-Mutated Uveal Melanoma.

Autor: Nguyen JQN; Department of Ophthalmology, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands.; Department of Clinical Genetics, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands., Drabarek W; The Rotterdam Eye Hospital, BH Rotterdam, The Netherlands., Leeflang AMCHJ; Department of Ophthalmology, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands.; Department of Clinical Genetics, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands., Brands T; Department of Ophthalmology, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands.; Department of Clinical Genetics, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands., van den Bosch TPP; Department of Pathology, Section Ophthalmic Pathology, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands., Verdijk RM; The Rotterdam Eye Hospital, BH Rotterdam, The Netherlands.; Department of Pathology, Section Ophthalmic Pathology, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, ZA Leiden, The Netherlands., van de Werken HJG; Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center Rotterdam, CA Rotterdam, The Netherlands.; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, CA Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, CA Rotterdam, The Netherlands., van Riet J; Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center Rotterdam, CA Rotterdam, The Netherlands.; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, CA Rotterdam, The Netherlands., Paridaens D; Department of Ophthalmology, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands.; The Rotterdam Eye Hospital, BH Rotterdam, The Netherlands., de Klein A; Department of Clinical Genetics, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands., Brosens E; Department of Clinical Genetics, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands., Kiliç E; Department of Ophthalmology, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands.

Publikováno v: Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2024 Oct 01; Vol. 65 (12), pp. 11.

Recurrent CLTC::SYK fusions and CSF1R mutations in juvenile xanthogranuloma of soft tissue.

Autor: Kemps PG; Princess Máxima Center for Pediatric Oncology, Netherlands., Baelde HJ; Leiden University Medical Center, Leiden, Netherlands., Vorderman RHP; Leiden University Medical Center, Leiden, Netherlands., Stelloo E; Solvias NL (formerly Cergentis bv), Utrecht, Netherlands., Swennenhuis JF; Cergentis BV, Utrecht, Netherlands., Szuhai K; Leiden University Medical Center, Leiden, Netherlands., Lamers MH; Leiden University Medical Center, Leiden, Netherlands., Kenkhuis B; Leiden University Medical Center, Amsterdam, Netherlands., Al-Hussaini M; King Hussein Cancer Center, Amman, Jordan., Briaire-de Bruijn I; Leiden University Medical Center, Leiden, Netherlands., Lam SW; Leiden University Medical Center, Leiden, Netherlands., Bovee JVMG; Leiden University Medical Center, Leiden, Netherlands., Cleven AH; University Medical Center Groningen, Groningen, Netherlands., Verdijk RM; Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands., van Noesel CJM; Amsterdam University Medical Centers, Location AMC, Amsterdam, Netherlands., van Dijk M; UMC Utrecht, Utrecht, Netherlands., Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Bruggink AH; Palga (Dutch Nationwide Pathology Databank), Houten, Netherlands., van Laar JA; Erasmus University Medical Center, rotterdam, Netherlands., de Vries ACH; Erasmus Medical Center, Sophia children's hospital, Rotterdam, Netherlands., Tissing W; Princess Máxima Center for Pediatric Oncology, Netherlands., van den Bos C; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., von Deimling A; University of Heidelberg, Heidelberg, Germany., van Wezel T; Leiden University Medical Center, Leiden, Netherlands., van Halteren AGS; Erasmus Medical Center, Rotterdam, Netherlands., Hogendoorn PCW; Leiden University Medical Center, Leiden, Netherlands.

Publikováno v: Blood [Blood] 2024 Sep 24. Date of Electronic Publication: 2024 Sep 24.

Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting.

Autor: Ventin M; Department of Surgery, Division of Gastrointestinal and Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Cattaneo G; Department of Surgery, Division of Gastrointestinal and Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Arya S; Department of Surgery, Division of Gastrointestinal and Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Jia J; Department of Surgery, Division of Gastrointestinal and Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Gelmi MC; Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands., Sun Y; Department of Medicine, Mass General Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Maggs L; Department of Surgery, Division of Gastrointestinal and Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Ksander BR; Department of Ophthalmology, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts., Verdijk RM; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Pathology, Section Ophtalmic Pathology, Erasmus Medical Center, Rotterdam, the Netherlands., Boland GM; Department of Surgery, Division of Gastrointestinal and Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Jenkins RW; Department of Medicine, Mass General Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Haq R; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Jager MJ; Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Ophthalmology, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts., Wang X; Department of Surgery, Division of Gastrointestinal and Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Ryeom S; Department of Surgery, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York., Ferrone CR; Department of Surgery, Division of Gastrointestinal and Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Surgery, Cedars Sinai Medical Center, Los Angeles, California.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Aug 01; Vol. 30 (15), pp. 3243-3258.

A Rare Case of Subconjunctival Nerve Sheath Myxoma Presenting as Orbital Fat Prolapse.

Autor: van Meyel SWF; Department of Orbital Oculoplastic and Lacrimal Surgery, The Rotterdam Eye Hospital., Verdijk RM; Department of Orbital Oculoplastic and Lacrimal Surgery, The Rotterdam Eye Hospital.; Department of Pathology, Erasmus MC University Medical Center Rotterdam.; Department of Ophthalmology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands., Therssen N; Department of Orbital Oculoplastic and Lacrimal Surgery, The Rotterdam Eye Hospital., Paridaens D; Department of Orbital Oculoplastic and Lacrimal Surgery, The Rotterdam Eye Hospital.; Department of Ophthalmology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.

Publikováno v: Ophthalmic plastic and reconstructive surgery [Ophthalmic Plast Reconstr Surg] 2024 Jul 30. Date of Electronic Publication: 2024 Jul 30.